
-
Flights cancelled as Belgium hit by national strike
-
Harmer's double strike has Pakistan 36-2, lead South Africa by 145
-
Google to invest $15 bn in India, build largest AI hub outside US
-
Gill wins first series as India captain with 2-0 West Indies sweep
-
Monetochka: voice of resistance and hope for anti-Putin Russians
-
AI content proliferates in Hungary ahead of next year's elections
-
Guinea circus school offers a springboard for disadvantaged youth
-
Sting finds fractured modern music scene 'quite odd'
-
South Africa dismissed for 269 in reply to Pakistan's 378
-
Rahul hits half-century as India beat West Indies to sweep series
-
Trump tariffs on timber, furniture take effect
-
Honduras beat Haiti 3-0 to top World Cup qualifying group
-
Falcons beat Bills while Bears edge Commanders in NFL
-
Dodgers edge Brewers, Mariners rout Jays in MLB playoffs
-
Purrno Noir? New Zealand company sells non-alcoholic wine for pets
-
US threats cast doubt on shipping emissions deal
-
North Korean refugees long for family behind impenetrable border
-
Asian stocks pare tariff-led losses, Tokyo hit by political turmoil
-
Honduras beats Haiti for World Cup qualifying group lead
-
Venezuelan Nobel winner says Maduro will leave power 'with or without' talks
-
After uprising, Nepal's Gen Z rush to register to vote
-
SpaceX launches Starship megarocket on successful test flight
-
SpaceX's launches Starship megarocket on successful test flight
-
Four Brazilians to watch at COP30
-
Brazil's climate wins ahead of COP30
-
Black gold, green promises: Brazil's climate paradox
-
Myanmar scam cities booming despite crackdown -- using Musk's Starlink
-
Australia doctors warn of 'excessive' medical weed prescriptions
-
Mariners rout Blue Jays to seize 2-0 lead in MLB playoffs
-
At least 64 dead, 65 missing in Mexico floods
-
Global goal to end deforestation nowhere near being met: experts
-
Star Copper Drill Program Mobilizes Additional Rig at Copper Creek to Test High Value Historic Target in BC
-
Apex Acquires Additional REE Rights and Consolidates Priority Target Area at The Elk Creek Rift Project, Nebraska
-
Empire Metals Limited - MRE Confirms World Dominant Titanium Discovery
-
SpaceX launches Starship test flight
-
NFL suspends Lions safety Branch for post-game scuffle
-
Cape Verde erupts in celebration after first World Cup qualification
-
France held in Iceland as Germany and Belgium close on 2026 World Cup
-
Madagascar's cornered president ignores calls to resign
-
MLB Padres manager Shildt retires over job's 'severe toll'
-
NFL Titans fire Callahan as coach after 1-5 start
-
Mateta off mark but France held by Iceland in World Cup qualifying
-
Wall Street stocks bounce after Trump-fueled slide
-
De Bruyne's penalty double fires Belgium to vital win over Wales
-
Woltemade header sends Germany past Northern Ireland
-
Trump takes victory lap in the Middle East
-
Brazil hopes Amazon summit can unite world for climate action
-
Nobel economist warns of AI dangers
-
Kane available to face Latvia as England aim to book World Cup place
-
Madagascar on edge as embattled president's address delayed

Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Wednesday, August 20, 2025, at 11:00 a.m. ET.
Ainos will highlight the uniqueness of its AI Nose technology, underscoring recent strategic partnerships and the rapid acceleration of AI Nose deployment. In addition, the Company will also share insights into market and scale-up opportunities across multiple sectors, outline key milestones expected for the remainder of 2025 and into 2026, and make the case for why Ainos should be regarded as a technology company at its core.
To register for this listen-only event, please visit:
Fireside Chat Registration Link
The replay of the fireside chat will be available under "Events" on Ainos' investor relations website at https://ir.ainos.com/.
About AI Nose
AI Nose digitizes scent into Smell ID, an AI-driven scent intelligence. This full-stack electronic nose (e-nose) platform combines precision MEMS sensor arrays with proprietary AI algorithms, aiming to detect scent at parts-per-billion (ppb) sensitivity. Smell ID then converts analog scent data into actionable insights, while the proprietary smell language model (SLM) learns complex scent patterns. Backed by a 13-year scent data moat and deep medtech expertise, AI Nose aims to deliver continuous monitoring, predictive analytics, and instant alerts to boost safety, quality, and efficiency. To be delivered as SmellTech-as-a-Service, it aims to offer subscription access to ongoing scent intelligence, analytics, and real-time alerts, turning the invisible into strategic advantage.
About Ainos, Inc.
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
Contact Information:
Feifei Shen
[email protected]
SOURCE: Ainos, Inc.
View the original press release on ACCESS Newswire
B.Finley--AMWN